医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

New Children’s Health Products Sell Out at Mannatech’s Asia MannaFest℠ 2016 Event

2016年11月07日 AM01:00
このエントリーをはてなブックマークに追加


 

SEOUL, Korea

Mannatech®, Incorporated (NASDAQ: MTEX), a global health and wellness company committed to changing lives to make a better world, sold out its pre-order of two newly launched children’s health products in the first half hour of its Asia MannaFest 2016 event at Olympic Park Handball Stadium, where thousands of its independent sales Associates gathered and enthusiastically embraced the new products.

At Asia MannaFest, Mannatech successfully introduced MultiKids™ supplement, an all-natural, strawberry-flavored children’s chewable multi-vitamin and MegaKids™ supplement, an omega-3 dietary supplement fortified with Vitamin D.

An estimated five thousand of the company’s independent sales Associates from the region were in attendance to learn more about the company’s new children’s health products and were the first to be able to purchase these new products.

“We are ecstatic by the acceptance and excitement that these new products have generated,” said Mannatech’s Regional President of Asia, Patrick Park. “Many families in Asia recognize the importance of children’s health, and Mannatech is able to provide families and children with products that will help support their specific health needs.”

In addition to the positive launch of these new products, Mannatech also shared its plans for expansion into China in the coming months through an approved e-commerce business model; a major unveiling that has launched a new wave of enthusiasm throughout Asia.

The company also recognized its TruHealth™ Master Challenge finalists, a competition which promotes a healthy lifestyle transformation using the company’s TruHealth Body Composition Management System, comprised of three products, including TruPLENISH™ Weight Control Shake, TruPURE™ Milk Thistle and Vitamin B6 Slimsticks and TruSHAPE™ Fat-Loss Capsules. The TruHealth Body Composition Management System continues to be one of the company’s best-selling product packs in Korea.

“Mannatech Associates can feel the passion and motivation the company has been working tirelessly to bring to Asia and all over the world,” said Mannatech’s CEO and President, Alfredo “Al” Bala. “We are looking forward to continuing our efforts, helping Associates achieve their dreams and bringing new opportunities for success in the future.”

To begin changing your life or the lives of those around you, please visit Mannatech.com.

About Mannatech

Mannatech, Incorporated, offers a profound wellness experience through a financially rewarding opportunity that makes a difference in the lives of people across the world. Through its innovative glyconutrition products, Mannatech changes lives, providing an unprecedented level of natural wellness, freedom and purpose. With more than 20 years of experience and operations in more than 25 countries, Mannatech is committed changing lives. For more information, visit Mannatech.com.

Please note: This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified by use of phrases or terminology such as “intend” or other similar words or the negative of such terminology. Similarly, descriptions of Mannatech’s objectives, strategies, plans, goals or targets contained herein are also considered forward-looking statements. Mannatech believes this release should be read in conjunction with all of its filings with the United States Securities and Exchange Commission and cautions its readers that these forward-looking statements are subject to certain events, risks, uncertainties and other factors. Some of these factors include, among others, Mannatech’s inability to attract and retain associates and members, increases in competition, litigation, regulatory changes and its planned growth into new international markets. Although Mannatech believes that the expectations, statements and assumptions reflected in these forward-looking statements are reasonable, it cautions readers to always consider all of the risk factors and any other cautionary statements carefully in evaluating each forward-looking statement in this release, as well as those set forth in its latest Annual Report on Form 10-K and Quarterly Report on Form 10-Q, and other filings filed with the United States Securities and Exchange Commission, including its current reports on Form 8-K. All of the forward-looking statements contained herein speak only as of the date of this release.

View source version on businesswire.com: http://www.businesswire.com/news/home/20161106005017/en/

CONTACT

Mannatech, Incorporated
Kalyn Dabbs, 972-471-7245
pr@mannatech.com

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • Vyome Presents on Development of Dual Action Rational Therapeutics (DARTs) to Treat Infections Caused by Antibiotic-Resistant Skin Opportunist Pathogens at Re-Entering Antibacterial Discovery and Development Summit 2016
  • CRISPRライセンシングのニーズに応えるMPEG LAイニシアチブ
  • 世界肺癌大会上呈报ABOUND数据,探索ABRAXANE®用于挑战性患者群体的安全性和有效性
  • Ajinomoto Is Awarded for the Contribution to Reduce Greenhouse Gas through Feed-Use L-Lysine
  • Ancillare宣布任命亚太区副总裁